
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The artificial cervical disc, also known as cervical disc replacement (CDR) or total disc arthroplasty, is a cutting-edge medical device designed to replicate the natural movement and function of a healthy spinal disc.Unlike fusion procedures that permanently join two vertebrae, the artificial disc is implanted between the affected vertebrae, allowing them to maintain independent motion.
This dynamic characteristic not only preserves the range of motion but also reduces the risk of adjacent segment degeneration, a potential complication of fusion surgeries. The implantation of an artificial cervical disc typically involves a minimally invasive surgical technique.This approach results in reduced tissue trauma, less postoperative pain, and quicker recovery times compared to traditional open spine surgeries.
Patients who undergo cervical disc replacement often experience significant relief from neck and arm pain and are able to resume their daily activities more rapidly. The artificial cervical disc is crafted from high-quality materials, such as medical-grade metal alloys or polymers, to ensure durability and biocompatibility within the body. Its design allows for smooth articulation, providing stability while allowing a range of movement similar to a natural disc.
Furthermore, the disc's surfaces are engineered to resist wear and promote longevity, minimizing the need for subsequent surgeries. Despite the numerous benefits, not all patients are suitable candidates for artificial cervical disc replacement.Factors such as severe spinal instability, extensive degeneration, or specific medical conditions may preclude some individuals from undergoing this procedure. A thorough evaluation by a spine specialist is essential to determine the most appropriate treatment for each patient's unique condition.
The Global Artificial cervical disc market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Mobi-C is an innovative medical device developed by Zimmer Biomet Holdings, Inc.It is a cervical disc replacement system designed to address degenerative cervical disc disease. Mobi-C offers a motion-preserving alternative to traditional fusion surgery, allowing patients to maintain more natural neck motion and potentially reducing adjacent-level disc degeneration.
The device features biocompatible materials, including cobalt chromium alloy and polyethylene, to promote long-term durability and compatibility with the body. Mobi-C aims to alleviate neck pain and maintain spinal stability, offering a promising solution for patients seeking relief from cervical disc-related issues and improving their quality of life.
Prodisc-C Vivo is a medical device developed by Centinel Spine, LLC, designed to treat cervical disc degeneration and related spinal conditions. It is an artificial cervical disc replacement system, offering a motion-preserving alternative to traditional fusion surgery.The device is designed to be inserted between the cervical vertebrae, maintaining the natural mobility of the spine while providing stability and reducing pain.
Prodisc-C Vivo aims to improve patients' quality of life by restoring normal neck movement and reducing pressure on adjacent spinal structures. As with any medical procedure, it should be evaluated and recommended by a qualified healthcare professional.
COMPANY | PRODUCT | YEAR | DESCRIPTION |
Zimmer Biomet | Mobi-C artificial disc | 2023 | The Mobi-C is a mobile-bearing disc that mimics the natural movement of the spine. |
NGMedical GmbH | MOVE-C | 2024 | MOVE-C combines the features of a second-generation viscoelastic disc prosthesis with the simple implantation technique of a cervical cage. MOVE®-C is the first prosthesis with additively manufactured titanium endplates and avoids the use of PE. |
Orthofix Medical | M6-C | 2021 | M6-C is a artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of contiguous two-level symptomatic cervical radiculopathy. |
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |